Mesenchymal Stem Cell-derived Exosomes: Applications in Cell-free Therapy
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Mesenchymal stem cells (MSCs) are an attractive resource for refractory patients because of their anti-inflammatory/immunomodulatory capability and multi-lineage differentiation potential. The transplantation of MSCs has led to positive results in preclinical and clinical application to various diseases, including autoimmune disease, cardiovascular disease, cancer, liver cirrhosis, and ischemic stroke. On the other hand, studies have shown that paracrine factors, not direct cell replacement for damaged cells or tissue, are the main contributors in MSC-based therapy. More recently, evidence has indicated that MSC-derived exosomes play crucial roles in regulating the paracrine factors that can mediate tissue regeneration via transferring nucleic acids, proteins, and lipids to the local microenvironment and cell-to-cell communication. The use of these exosomes is likely to be beneficial for the therapeutic application of MSCs because their use can avoid harmful effects, such as tumor formation involved in cell transplantation. Therefore, therapeutic applications using MSC-derived exosomes might be safe and efficient strategies for regenerative medicine and tissue engineering. This review summarizes the recent advances and provides a comprehensive understanding of the role of MSC-derived exosomes as a therapeutic agent.
Abstract
Mesenchymal stem cells (MSCs) are an attractive resource for refractory patients because of their anti-inflammatory/immunomodulatory capability and multi-lineage differentiation potential. The transplantation of MSCs has led to positive results in preclinical and clinical application to various diseases, including autoimmune disease, cardiovascular disease, cancer, liver cirrhosis, and ischemic stroke. On the other hand, studies have shown that paracrine factors, not direct cell replacement for damaged cells or tissue, are the main contributors in MSC-based therapy. More recently, evidence has indicated that MSC-derived exosomes play crucial roles in regulating the paracrine factors that can mediate tissue regeneration via transferring nucleic acids, proteins, and lipids to the local microenvironment and cell-to-cell communication. The use of these exosomes is likely to be beneficial for the therapeutic application of MSCs because their use can avoid harmful effects, such as tumor formation involved in cell transplantation. Therefore, therapeutic applications using MSC-derived exosomes might be safe and efficient strategies for regenerative medicine and tissue engineering. This review summarizes the recent advances and provides a comprehensive understanding of the role of MSC-derived exosomes as a therapeutic agent.
참고문헌 (53)
- 허준석, "Chondrogenic Differentiation of Human Mesenchymal Stem Cells on a Patterned Polymer Surface", 대한임상검사과학회지, 47(3), pp.117~124 (2015), 대한임상검사과학회
- Wang LT, "Human mesenchymal stem cells(MSCs)for treatment towards immune-and inflammation-mediated diseases : review of current clinical trials", J Biomed Sci, 23, pp.76~ (2016)
- Lee PH, "A randomized trial of mesenchymal stem cells in multiple system atrophy", Ann Neurol, 72, pp.32~40 (2012)
- Hodgkinson CP, "Emerging concepts in paracrine mechanisms in regenerative cardiovascular medicine and biology", Circ Res, 118, pp.95~107 (2016)
- Toma C, "Fate of culture-expanded mesenchymal stem cells in the microvasculature : in vivo observations of cell kinetics", Circ Res, 104, pp.398~402 (2009)
- Yu B, "Exosomes derived from mesenchymal stem cells", Int J Mol Sci, 15, pp.4142~4157 (2014)
- Kordelas L, "MSC-derived exosomes : a novel tool to treat therapy-refractory graft-versus-host disease", Leukemia, 28, pp.970~973 (2014)
- Zhang B, "Mesenchymal stem cells secrete immunologically active exosomes", Stem Cells Dev, 23, pp.1233~1244 (2014)
- Cho BS, "Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis", Stem Cells Res Ther, 9, pp.187~ (2018)
- Friedenstein AJ, "Osteogenesis in transplants of bone marrow cells", J Embryol Exp Morphol, 16, pp.381~390 (1966)
- Campagnoli C, "Identification of mesenchymal stem", progenitor cells in human first-trimester fetal blood, liver, and bone marrow, 2001, pp.98, 2396~2402
- In‘t Anker PS, "Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential", Haematologica, 88, pp.845~852 (2003)
- Haynesworth SE, "Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies", Bone, 13, pp.69~80 (1992)
- Le Blanc K, "Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation", Biol Blood Marrow Transplant, 11, pp.321~334 (2005)
- Majumdar MK, "Human marrow-derived mesenchymal stem cells(MSCs)express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages", J Hematother Stem Cell Res, 9, pp.841~848 (2000)
- Subramanian K, "Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow", Methods Mol Biol, 636, pp.55~78 (2010)
- Jiang XX, "Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells", Blood, 105, pp.4120~4126 (2005)
- Rombouts WJ, "Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture", Leukemia, 17, pp.160~170 (2003)
- Cilloni D, "Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation", Blood, 96, pp.3637~3643 (2000)
- Lazarus HM, "Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells(mesenchymal progenitor cells) : implications for therapeutic use", Bone Marrow Transplant, 16, pp.557~564 (1995)
- Wang S, "Clinical applications of mesenchymal stem cells", J Hematol Oncol, 5, pp.19~ (2012)
- Jung J, "Human placenta-derived mesenchymal stem cells promote hepatic regeneration in CCl4-injured rat liver model via increased autophagic mechanism", Stem Cells, 31, pp.1584~1596 (2013)
- Jeong H, "Mesenchymal stem cell therapy for ischemic heart disease : systematic review and meta-analysis", Int J Stem Cells, 11, pp.1~12 (2018)
- Harding C, "Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes", J Cell Biol, 97, pp.329~339 (1983)
- Théry C, "Isolation and characterization of exosomes from cell culture supernatants and biological fluids", Curr Protoc Cell Biol, 3, pp.22~ (2006)
- Kahlert C, "Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer", J Biol Chem, 289, pp.3869~3875 (2014)
- Booth AM, "Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane", J Cell Biol, 172, pp.923~935 (2006)
- Lai RC, "Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease", Regen Med, 6, pp.481~492 (2011)
- Vajihe Taghdiri Nooshabadi, "The extracellular vesicles-derived from mesenchymal stromal cells: A new therapeutic option in regenerative medicine", Journal of Cellular Biochemistry, 119(10), pp.8048~8073 (2018), Wiley[DOI]
- Yeo RW, "Mesenchymal stem cell : an efficient mass producer of exosomes for drug delivery", Adv Drug Deliv Rev, 65, pp.336~341 (2013)
- Dioufa N, "Bi-directional exosome-driven intercommunication between the hepatic niche and cancer cells", Mol Cancer, 16, pp.172~ (2017)
- Furlani D, "Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy", Microvasc Res, 77, pp.370~376 (2009)
- Breitbach M, "Potential risks of bone marrow cell transplantation into infarcted hearts", Blood, 110, pp.1362~1369 (2007)
- Mathivanan S, "ExoCarta : a compendium of exosomal proteins and RNA", Proteomics, 9, pp.4997~5000 (2009)
- Chen TS, "Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs", Nucleic Acids Res, 38, pp.215~224 (2010)
- Feng Y, "Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22", PLoS One, 9, pp.e88685~ (2014)
- Katakowski M, "Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth", Cancer Lett, 335, pp.201~204 (2013)
- Xin H, "MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles", Stem Cells, 31, pp.2737~2746 (2013)
- Amarnath S, "Bone marrow-derived mesenchymal stromal cells harness purinergenic signaling to tolerize human Th1 cells in vivo", Stem Cells, 33, pp.1200~1212 (2015)
- Shigemoto-Kuroda T, "MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models : type 1 diabetes and uveoretinitis", Stem Cell Reports, 8, pp.1214~1225 (2017)
- Zhang B, "Immunotherapeutic potential of extracellular vesicles", Front Immunol, 5, pp.518~ (2014)
- Bai L, "Effects of mesenchymal stem cell-derived exosomes on experimental autoimmune uveitis", Sci Rep, 7, pp.4323~ (2017)
- Cosenza S, "Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis", Theranostics, 8, pp.1399~1410 (2018)
- Shao L, "MiRNA-sequence indicates that mesenchymal stem cells and exosomes have similar mechanism to enhance cardiac repair", Biomed Res Int, 2017, pp.4150705~ (2017)
- Bian S, "Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model", J Mol Med, 92, pp.387~397 (2014)
- Teng X, "Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation", Cell Physiol Biochem, 37, pp.2415~2424 (2015)
- Feng Y, "Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22", PLoS One, 9, pp.e88685~ (2014)
- Zhang Z, "Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair", J Am Heart Assoc, 5, pp.e002856~ (2016)
- Yijin Wang, "Hepatitis E virus infection in acute non-traumatic neuropathy: A large prospective case-control study in China", EBioMedicine, 36, pp.122~130 (2018), Elsevier BV[DOI]
- Fiore EJ, "Mesenchymal stem", stromal cells in liver fibrosis : recent findings, old, Stem Cell Rev, pp.2015, 11[DOI]
- Tan CY, "Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models", Stem Cell Res Ther, 5, pp.76~ (2014)
- Ko SF, "Adipose-derived mesenchymal stem cell exosomes suppress hepatocellular carcinoma growth in a rat model : apparent diffusion coefficient, natural killer T-cell responses, and histopathological features", Stem Cells Int, 2015, pp.853506~ (2015)
- Hyun J, "MicroRNA125b-medicated hedgehog signaling influences liver regeneration by chorionic plate-derived mesenchymal stem cells", Sci Rep, 5, pp.14135~ (2015)